BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11044091)

  • 21. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
    Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
    Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
    J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
    Yoo LI; Mooney M; Puglielli MT; Speck SH
    J Virol; 1997 Dec; 71(12):9134-42. PubMed ID: 9371570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
    Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
    Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.
    Cotter M; Callahan J; Aster J; Robertson E
    J Virol; 2000 Feb; 74(3):1486-94. PubMed ID: 10627560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Woisetschlaeger M; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
    Tierney RJ; Steven N; Young LS; Rickinson AB
    J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing.
    Takacs M; Myöhänen S; Altiok E; Minarovits J
    Biol Chem; 1998; 379(4-5):417-22. PubMed ID: 9628332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter.
    Contreras-Brodin B; Karlsson A; Nilsson T; Rymo L; Klein G
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1159-62. PubMed ID: 8683201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
    J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
    Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenotypes of latent herpesvirus genomes.
    Minarovits J
    Curr Top Microbiol Immunol; 2006; 310():61-80. PubMed ID: 16909907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).
    Puglielli MT; Desai N; Speck SH
    J Virol; 1997 Jan; 71(1):120-8. PubMed ID: 8985330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
    Woisetschlaeger M; Jin XW; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3942-6. PubMed ID: 1850841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
    Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
    Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial.
    Robertson KD; Hayward SD; Ling PD; Samid D; Ambinder RF
    Mol Cell Biol; 1995 Nov; 15(11):6150-9. PubMed ID: 7565767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.
    Hughes DJ; Dickerson CA; Shaner MS; Sample CE; Sample JT
    J Virol; 2011 Nov; 85(21):11435-47. PubMed ID: 21865378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.